Literature DB >> 6436764

von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

R A Lewis, L P Gerson, K A Axelson, V M Riccardi, R P Whitford.   

Abstract

The association of optic glioma with von Recklinghausen neurofibromatosis (NF) is well established. However, the incidence of these tumors in a large population of NF patients, prospectively evaluated with modern radiologic techniques, has not been established. We investigated the ophthalmic and intracranial features of NF in 217 patients aged 4 weeks to 69 years, in whom the diagnosis was based on stringent criteria. Tumors at various locations along the anterior visual pathway occurred in 15% of patients and were occasionally bilateral. The mean age of patients with chiasmal tumors was approximately 15 years less than patients with tumors of the optic nerve only. Two-thirds (67%) of all tumors were neither suspected historically nor detected by ophthalmologic examination. Neither the ophthalmoscopic absence of optic atrophy nor the normal results of roentgenograms of the optic foramina were reliable predictors of tumors detected by CT scan. The presence of optic glioma is not correlated to other ocular, skeletal, neurologic, or anamnestic risk factors.

Entities:  

Mesh:

Year:  1984        PMID: 6436764     DOI: 10.1016/s0161-6420(84)34217-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  55 in total

1.  Growth in North American white children with neurofibromatosis 1 (NF1).

Authors:  J Szudek; P Birch; J M Friedman
Journal:  J Med Genet       Date:  2000-12       Impact factor: 6.318

Review 2.  Neoplasms associated with germline and somatic NF1 gene mutations.

Authors:  Sachin Patil; Ronald S Chamberlain
Journal:  Oncologist       Date:  2012-01-12

3.  Uveal malignant melanoma and optic nerve glioma in von Recklinghausen's neurofibromatosis.

Authors:  C M Antle; K F Damji; V A White; J Rootman
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

Review 4.  A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling.

Authors:  S M Huson; D A Compston; P S Harper
Journal:  J Med Genet       Date:  1989-11       Impact factor: 6.318

Review 5.  Optimizing biologically targeted clinical trials for neurofibromatosis.

Authors:  David H Gutmann; Jaishri O Blakeley; Bruce R Korf; Roger J Packer
Journal:  Expert Opin Investig Drugs       Date:  2013-02-21       Impact factor: 6.206

6.  Deletions on the long arm of chromosome 17 in pilocytic astrocytoma.

Authors:  A von Deimling; D N Louis; A G Menon; K von Ammon; I Petersen; D Ellison; O D Wiestler; B R Seizinger
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Glioblastoma multiforme in the posterior cranial fossa in a patient with neurofibromatosis type I.

Authors:  Marike L D Broekman; Roelof Risselada; Jooyeon Engelen-Lee; Wim G M Spliet; Bon H Verweij
Journal:  Case Rep Med       Date:  2009-12-16

Review 8.  Visual function tests including the role of optical coherence tomography in neurofibromatosis 1.

Authors:  Daphna Mezad-Koursh; Anat Bachar Zipori; Dinah Zur; Lior Degabli; Meital Ben-Dov; Ainat Klein
Journal:  Childs Nerv Syst       Date:  2020-08-04       Impact factor: 1.475

Review 9.  An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

Authors:  M Garvey; R J Packer
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

Review 10.  Special issues in the management of gliomas in children with neurofibromatosis 1.

Authors:  I F Pollack; J J Mulvihill
Journal:  J Neurooncol       Date:  1996 May-Jun       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.